Did you know that 60 percent of pharmaceutical production is outsourced? As drug development costs rise, CDMOs have become safe havens for biopharma companies by offering scalable, cost-effective, and cutting-edge technology solutions for drug development and manufacturing.  In March, PharmaShots Magazine is navigating the evolving Biopharma CDMO frontier by decoding trends, illustrative infographics, thought-provoking articles,…